Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2002-04-01 (24 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13014), Bouches-du-Rhone
PHARMACIE DESVILLES DORE : revenue, balance sheet and financial ratios
PHARMACIE DESVILLES DORE is a French company
founded 24 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13014),
this company of category PME
shows in 2022 a revenue of 4.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DESVILLES DORE (SIREN 441354875)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
4 474 242 €
N/C
N/C
3 892 744 €
4 265 702 €
4 260 954 €
4 434 358 €
Net income
181 346 €
397 696 €
430 113 €
428 093 €
73 057 €
121 839 €
178 548 €
133 346 €
205 459 €
EBITDA
N/C
N/C
458 902 €
N/C
N/C
149 225 €
261 867 €
133 140 €
259 590 €
Net margin
N/C
N/C
9.6%
N/C
N/C
3.1%
4.2%
3.1%
4.6%
Revenue and income statement
In 2024, PHARMACIE DESVILLES DORE generates positive net income of 181 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 205 k€ -> 181 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
181 346 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 77%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
77.442%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.0%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
59.944
59.513
51.124
56.384
88.739
74.0
75.242
184.685
77.442
Financial autonomy
52.108
52.191
54.343
54.253
46.359
50.897
49.903
34.963
49.0
Repayment capacity
6.059
7.929
5.182
10.493
None
None
7.441
None
None
Cash flow / Revenue
4.12%
3.15%
4.296%
2.555%
None%
None%
10.304%
None%
None%
Sector positioning
Debt ratio
77.442024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE DESVILLES DORE (77.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.0%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DESVILLES DORE (49.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.44 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DESVILLES DORE (7.44) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 148.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
111.908
95.189
88.886
102.905
144.375
230.845
236.59
3474.275
148.979
Interest coverage
6.707
16.411
8.361
15.536
None
None
2.405
None
None
Sector positioning
Liquidity ratio
148.982024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-28 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DESVILLES DORE (148.98) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.4x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE DESVILLES DORE (2.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DESVILLES DORE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
438 558 €
431 251 €
433 950 €
427 540 €
0 €
0 €
1 032 431 €
0 €
0 €
Inventory turnover (days)
37
38
32
30
0
0
83
0
0
Customer payment term (days)
3
5
11
12
42
80
4
0
0
Supplier payment term (days)
50
47
53
48
284
258
100
0
0
Positioning of PHARMACIE DESVILLES DORE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DESVILLES DORE is estimated at
2 531 724 €
(range 1 763 052€ - 3 787 604€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1763k€2531k€3787k€
2 531 724 €Range: 1 763 052€ - 3 787 604€
NAF 5 année 2024
Valuation method used
Net Income Multiple
181 346 €
×
14.0x
=2 531 724 €
Range: 1 763 053€ - 3 787 604€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DESVILLES DORE with other companies in the same sector:
Frequently asked questions about PHARMACIE DESVILLES DORE
What is the revenue of PHARMACIE DESVILLES DORE ?
The revenue of PHARMACIE DESVILLES DORE in 2022 is 4.5 M€.
Is PHARMACIE DESVILLES DORE profitable?
Yes, PHARMACIE DESVILLES DORE generated a net profit of 181 k€ in 2024.
Where is the headquarters of PHARMACIE DESVILLES DORE ?
The headquarters of PHARMACIE DESVILLES DORE is located in MARSEILLE (13014), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DESVILLES DORE ?
The tax return of PHARMACIE DESVILLES DORE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DESVILLES DORE operate?
PHARMACIE DESVILLES DORE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart